ECE2023 Rapid Communications Rapid Communications 3: Pituitary and Neuroendocrinology 1 (6 abstracts)
Increased intracellular and extracellular myocardial mass on cardiac magnetic resonance imaging in patients with acromegaly
Peter Wolf 1,2 , Khaoula Bouazizi 3 , Nadjia Kachenoura 3 , Celine Piedvache 4 , Antonio Gallo 5 , Sylvie Salenave 2 , Luigi Maione 2 , Jacques Young 2 , Mikael Prigent 3 , Anne-Lise Lecoq 2 , Emmanuelle Kuhn 2 , Helene Agostini 4 , Severine Trabado 6 , Alban Redheuil 7 , Philippe Chanson 2 & Peter Kamenicky 2
1Medical University of Vienna, Internal Medicine III, Endocrinology and Metabolism, Vienna, Austria; 2Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Le Kre mlin-Bicêtre, France; 3Institut de Cardiométabolisme et Nutrition (ICAN), Paris, France; 4Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Unité de Recherche Clinique, Le Kre mlin-Bicêtre, France; 5Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France; 6Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Le Kre mlin-Bicêtre, France; 7Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Unité d’Imagerie Cardiovasculaire et Thoracique, Paris, France
Background: Acromegaly is associated with an increased left ventricular mass, as reported in echo-based and more recently in few cardiac MRI studies. One possible explanation of this increased ventricular mass could be water retention and consequently edema of the ventricular wall.
Methods: In this prospective, cross-sectional study 26 patients with active acromegaly and 31 control subjects of comparable age and sex were investigated by cardiac MRI. Patients were explored before and after GH/IGF-I lowering treatment. Cardiac morphology, function and myocardial tissue characteristics were assessed. T2 times were used as a reflect of intramyocardial water content.
Results: Ventricular mass (58.1 (54.7; 68.6) vs 46.0 (41.3; 49.8) g/m2; P<0.001) and volume (97.3 (88; 101.2) vs 81.6 (78.0; 96.2) ml/m2; P=0.0069) were higher in patients compared to controls, without affecting cardiac function. T2 times were not increased in active acromegaly. Both, intracellular (87.9 (71.2; 103.6) vs 67.2 (51.6; 76.9) g/m2; P<0.001) and extracellular (31.9 (26.1; 36.6) vs 21.8 (19.2;24.7) g/m2; P<0.001) myocardial mass were higher in patients compared to controls. GH, but not IGF-I strongly correlated with myocardial mass (r=0.756; P<0.001). In multiple regression analysis, in addition to male sex and HDL cholesterol, the presence of acromegaly was an independent predictor of total myocardial mass and extracellular mass, whereas systolic arterial blood pressure predicted intracellular mass. GH/IGF-I lowering treatment reduced intracellular mass and ventricular volume, without affecting other myocardial tissue characteristics.
Discussion: Acromegaly results in a disease specific form of myocardial hypertrophy, characterized by an increase in intra- and extracellular mass, which is reversed after GH/IGF-I lowering treatment. This increase in ventricular mass is different to previous observations in essential hypertension. No differences in T2 times suggest against myocardial water retention in active acromegaly as explication of increased extracellular mass.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more